Century Therapeutics IPSC
NASDAQ IPSC
$1.58 -0.03 (-1.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Preferred Shares (2020)

Updated

Century Therapeutics' Preferred Shares came in at $179.76 million for Q4 2020.

Analysis

Century Therapeutics (IPSC) Preferred Shares (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Century Therapeutics 285.26 Mn -219.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 179.76 Mn
API Access

Century Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=IPSC&period=max&api_key=YOUR_API_KEY